Citizens Maintains Market Outperform on NICE, Lowers Price Target to $170

Benzinga Newsdesk www.benzinga.com Negative 91.8%

Neg 91.8% Neu 0% Pos 0%

Citizens analyst Patrick Walravens maintains NICE (NASDAQ:NICE) with a Market Outperform and lowers the price target from $200 to $170.